Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Suisse (CSUI) EBITDA Margin (2016 - 2025)

Cannabis Suisse has reported EBITDA Margin over the past 8 years, most recently at 876.36% for Q1 2025.

  • Quarterly EBITDA Margin fell 5236.0% to 876.36% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 3681.81% through Nov 2025, down 265341.0% year-over-year, with the annual reading at 1261.2% for FY2025, 41889.0% down from the prior year.
  • EBITDA Margin was 876.36% for Q1 2025 at Cannabis Suisse, up from 1216.64% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 524.7% in Q4 2021 and troughed at 6199.64% in Q1 2023.
  • The 4-year median for EBITDA Margin is 851.61% (2023), against an average of 1399.72%.
  • Year-over-year, EBITDA Margin crashed -139436bps in 2021 and then soared 537564bps in 2024.
  • A 4-year view of EBITDA Margin shows it stood at 524.7% in 2021, then fell by -26bps to 661.88% in 2023, then plummeted by -84bps to 1216.64% in 2024, then increased by 28bps to 876.36% in 2025.
  • Per Business Quant, the three most recent readings for CSUI's EBITDA Margin are 876.36% (Q1 2025), 1216.64% (Q4 2024), and 983.71% (Q3 2024).